Relevant nursing measures for the adverse reactions associated with chimeric antigen receptor T cells (CAR-T) immunotherapy: a systematic review of case reports†
Cytokine release syndrome (CRS) and tumor lysis syndrome (TLS) that occur after chimeric antigen receptor T (CAR-T) cells are reinfused, which severely affect the survival and prognosis of patients. Although several articles have reported on the care of CAR-T cell immunotherapy, the quality of the s...
Main Authors: | Zhang Xu, Sun Di, Jiang Gui-Chun |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2019-07-01
|
Series: | Frontiers of Nursing |
Subjects: | |
Online Access: | https://doi.org/10.2478/FON-2019-0014 |
Similar Items
-
T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy
by: Elien De Bousser, et al.
Published: (2021-12-01) -
The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
by: Dongfang Liu, et al.
Published: (2020-08-01) -
Immunotherapy for B-Cell Neoplasms using T Cells expressing Chimeric Antigen Receptors : From antigen choice to clinical implementation
by: Mohamed-Rachid Boulasse, et al.
Published: (2012-08-01) -
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
by: Giuseppe Schepisi, et al.
Published: (2023-03-01) -
Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
by: Long Chen, et al.
Published: (2022-07-01)